Google Alert - hepatitis c

[Guest guest]

Google News Alert for: hepatitis c

BioWatch: HGS seeks OK for hepatitis C treatmentBusiness Gazetteby Gazette Staff | As expected, Human Genome Sciences has applied for federal regulatory approval to market its new treatment for hepatitis C. The Rockville ...See all stories on this topic

Study links Latino immigrants' HIV risk to level of adaptation to U.S. cultureLos Angeles TimesThey also tended to be tested for HIV later than other ethnic groups and to be more likely than whites to also have hepatitis C, which can be associated ...See all stories on this topic

Raju back in jail, causes feud over the bill amountDaily News & AnalysisAfter putting him through a series of tests at the ICCU in the hospital, he was diagnosed to be suffering from Hepatitis C, apart from heart ailment. ...See all stories on this topic

This once a day Google Alert is brought to you by Google.

[Guest guest]

News

8 new results for hepatitis c

Drug Firms Liable In Vegas Hepatitis C Case, Jury FindsHuffington PostThe man, Henry Chanin, claimed he contracted hepatitis C during a routine endoscopy procedure in 2006. The companies have appealed that case to the Nevada Supreme Court. Eglet and Kemp asked the jury in the current case to award $25 million to their ...See all stories on this topic »

New Hepatitis C Guide Book Released: Lloyd 's Hep C Health Guide Book a ...San Francisco Chronicle (press release)Lloyd has released a new book, Hepatitis C: A Do-It Yourself Guide for Health, that has extremely valuable information for those suffering with Hepatitis C, a devstating chronic disease. Lloyd , author of the just released Hepatitis C: A ...See all stories on this topic »

New Hep C Treatment Guidelines Spell Out Incivek and Victrelis UseAIDSmeds.com HIV/AIDS Treatment NewsRevised treatment guidelines from the American Association for the Study of Liver Diseases (AASLD) outline a significant change in the standard of care for people with genotype 1 chronic hepatitis C virus (HCV) infection. ...See all stories on this topic »

Plaintiffs' Attorneys Ask for Millions in Punitive DamagesKLAS-TVBy Zahid Arab, Reporter - bio | email By Mark Zamora, Photojournalist - email LAS VEGAS -- The jury in the hepatitis C trial has been sent home for the day. The panel will start again Monday to deliberate whether three drug companies involved in the ...See all stories on this topic »

Hepatitis C Virus May Increase The Risk Of Brain Disorders And Death In People ...The AIDS BeaconResults from a recent study indicate that brain disorders, particularly epilepsy and seizures, are more common in HIV-positive patients with hepatitis C virus than in patients with HIV alone. The risk of death was also higher for these individuals. ...See all stories on this topic »

Boehringer signs away HIV rights to focus on hep CInPharmThe deal will allow Boehringer to concentrate on other areas of its virology portfolio, in particular hepatitis C where its lead compound - BI 201335 – moved into Phase III trials earlier this year. The deal with Gilead, already a dominant force in the ...See all stories on this topic »

InPharm

sludge sends hospital staff for HIV testsToronto Sun(MIKE DREW/QMI Agency) At least 100 hospital staffers voluntarily submitted themselves for HIV, Hepatitis B and Hepatitis C tests following a drainage problem at the facility. The voluntary tests were offered to staff and students of the Lougheed ...See all stories on this topic »

Drug companies found liable in hepatitis C infectionsLas Vegas Review - JournalBy Haynes A jury found three drug companies on Thursday liable for the infections of three former patients at the clinics linked to the hepatitis C outbreak. The jury also awarded a total of $20.1 million in compensatory damages and said punitive ...See all stories on this topic »

- more news

http://health.dir./group/ /links/025___HCV_DAILY_NEWS_RESOURCES_001268599268/

[Guest guest]

News

9 new results for hepatitis c

Inhibitex Doubles as Hepatitis C Drug Proves Active in TrialBusinessWeek4 (Bloomberg) -- Inhibitex Inc., the maker of an experimental drug to treat infections associated with the hepatitis C virus, more than doubled as the medicine showed antiviral activity with no serious side effects in a study. Inhibitex soared $4.58 to ...See all stories on this topic »

Hepatitis C Birth Cohort Screening is Cost-EffectiveDoctors LoungeBirth cohort screening can be a cost-effective strategy to identify individuals infected with hepatitis C virus, according to a study published online Nov. 4 in the ls of Internal Medicine. FRIDAY, Nov. 4 (HealthDay News) -- Birth cohort screening ...See all stories on this topic »

Vertex awards $1.5M to help Hepatitis C patientsMass High TechBy M. Connolly Vertex Pharmaceuticals Inc. (Nasdaq: VRTX) today awarded 16 grants worth $1.5 million to academic, patient and community groups that are supporting people living with chronic hepatitis C. Cambridge-based Vertex said the Vertex ...See all stories on this topic »

Mass High Tech

Hepatitis C transmission via injecting drug use: look beyond needles and syringesaidsmapImportant insights into the continued spread of hepatitis C among injecting drug users are provided by two studies published in the online edition of the Journal of Infectious Diseases. An international team of investigators showed that infectious ...See all stories on this topic »

New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination ...MarketWatch (press release)"Hepatitis C is a rapidly evolving field of research. As the science evolves, we are evolving our clinical development programs to continue to drive advances in HCV research," said s, senior vice president, Development,

Bristol-Myers Squibb ...See all stories on this topic »

Ottawa infection scare leads to endoscopy anxietiesCBC.caIn mid-October, Ottawa Public Health sent letters out to patients who visited the clinic of Dr. Christiane Farazli between April 2002 and June 2011, advising them to get checked for hepatitis B, hepatitis C and HIV. Dr. Isra Levy, Ottawa's chief ...See all stories on this topic »

CBC.ca

Vertex Announces Recipients of Special Grants Initiative to Support People ...BenzingaIn the United States, nearly 4 million people have chronic hepatitis C and an estimated 75 percent of them are unaware of their infection1. This high burden of disease has significant medical, social and economic consequences. ...See all stories on this topic »

Liver Lines: November 3, 2011Plainview Old Bethpage HeraldI must say that the newly approved hepatitis C treatments have been a pleasant surprise. In May of this year, the FDA approved two new combination therapies for patients with hepatitis C. These therapies are a combination of two older medications, ...See all stories on this topic »

Enhancement of Humoral Immunity in Mice by coupling pUCpGs10 and Aluminium to ...7thSpace Interactive (press release)Aim: To investigate the enhancement of humoral immunity when CpG ODN (cytidine phosphate guanosine oligodeoxynucleotides) and aluminium adjuvants are complexed with the HCV ( Hepatitis C virus) recombinant immunogen in mice. ...See all stories on this topic »

- more news

http://health.dir./group/ /links/025___HCV_DAILY_NEWS_RESOURCES_001268599268/